Home › Steatotic Liver Disease › Arizona › Phoenix
Steatotic Liver Disease clinical trials in Phoenix, AZ
4 studies for Steatotic Liver Disease are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Early Tracking of Childhood Health Determinants (ETCHED) Study
RecruitingObservational studyHealthy volunteers welcome
- NIDDK, Phoenix, Phoenix
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Phoenix
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RecruitingPhase 2
- GSK Investigational Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
RecruitingPhase 4Healthy volunteers welcome
- Banner Health Center, Phoenix
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Hialeah, FL9 studies
- Orlando, FL9 studies
- Dallas, TX9 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.